DNA synthesis rate (2) and the [‘8F]fluorodeoxyglucose (FDG) PET method allows noninvasive measurement of tumor grade, prognosis and recurrence (3—10).However, FDG uptakeinvolves a process common to both tumorand nontumor tissues. In tumor tissues, FDG uptake is related to inflammatory and neoplastic cells (11); in nontumor tissues (i.e., normal brain, abscesses, scar or epileptic focus), the tracer uptake could hamper the interpretation of the tumor's uptake (12). These potential drawbacks could be circumvented by developing a more selective tumor tracer. During the last decade, PET imaging with “C-labeledthymidine (Tdr) was developed to measure noninvasively cellular proliferation (13,14). Previous data obtained in a partial he...
Development of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F) fluoro-2-...
The distinct metabolism of cancer cells relying on glycolysis is gaining renewed attention as a “hal...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...
Positron emission tomography (PET) with [18F]-FDG is now firmly established as a clinical tool in on...
Positron emission tomography (PET) with {F-18}-FDG is nowfirmly established as a clinical tool in on...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...
The positron emission tomography (PET) tracer 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) has been p...
Imaging biomarkers have a potential to depict the hallmarks of cancers that characterise cancer cell...
Background: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantif...
AbstractImaging biomarkers have a potential to depict the hallmarks of cancers that characterise can...
<div><p>Background</p><p>Non-invasive imaging biomarkers of cellular proliferation hold great promis...
The thymidine analog 18F-3-deoxy-3-fluorothymidine (FLT) is being used clinically for PET imaging of...
Development of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F) fluoro-2-...
Twenty-five patients with mass lesions involving the muscu-toskeletat system were studied with posit...
Objective: The uptake of 3′-[18F]fluoro-3′- deoxythymidine (FLT), a proliferation marker, was measur...
Development of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F) fluoro-2-...
The distinct metabolism of cancer cells relying on glycolysis is gaining renewed attention as a “hal...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...
Positron emission tomography (PET) with [18F]-FDG is now firmly established as a clinical tool in on...
Positron emission tomography (PET) with {F-18}-FDG is nowfirmly established as a clinical tool in on...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...
The positron emission tomography (PET) tracer 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) has been p...
Imaging biomarkers have a potential to depict the hallmarks of cancers that characterise cancer cell...
Background: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantif...
AbstractImaging biomarkers have a potential to depict the hallmarks of cancers that characterise can...
<div><p>Background</p><p>Non-invasive imaging biomarkers of cellular proliferation hold great promis...
The thymidine analog 18F-3-deoxy-3-fluorothymidine (FLT) is being used clinically for PET imaging of...
Development of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F) fluoro-2-...
Twenty-five patients with mass lesions involving the muscu-toskeletat system were studied with posit...
Objective: The uptake of 3′-[18F]fluoro-3′- deoxythymidine (FLT), a proliferation marker, was measur...
Development of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F) fluoro-2-...
The distinct metabolism of cancer cells relying on glycolysis is gaining renewed attention as a “hal...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...